JP2023548560A5 - - Google Patents

Info

Publication number
JP2023548560A5
JP2023548560A5 JP2023527041A JP2023527041A JP2023548560A5 JP 2023548560 A5 JP2023548560 A5 JP 2023548560A5 JP 2023527041 A JP2023527041 A JP 2023527041A JP 2023527041 A JP2023527041 A JP 2023527041A JP 2023548560 A5 JP2023548560 A5 JP 2023548560A5
Authority
JP
Japan
Prior art keywords
bases
cells
actuator portion
item
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548560A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058331 external-priority patent/WO2022099069A1/en
Publication of JP2023548560A publication Critical patent/JP2023548560A/ja
Publication of JP2023548560A5 publication Critical patent/JP2023548560A5/ja
Pending legal-status Critical Current

Links

JP2023527041A 2020-11-08 2021-11-05 遺伝子の発現または活性を調節するための系および方法 Pending JP2023548560A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063111053P 2020-11-08 2020-11-08
US63/111,053 2020-11-08
US202163216659P 2021-06-30 2021-06-30
US63/216,659 2021-06-30
PCT/US2021/058331 WO2022099069A1 (en) 2020-11-08 2021-11-05 Systems and methods for regulating gene expression or activity

Publications (2)

Publication Number Publication Date
JP2023548560A JP2023548560A (ja) 2023-11-17
JP2023548560A5 true JP2023548560A5 (https=) 2024-10-31

Family

ID=81457425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527041A Pending JP2023548560A (ja) 2020-11-08 2021-11-05 遺伝子の発現または活性を調節するための系および方法

Country Status (5)

Country Link
US (1) US20240067991A1 (https=)
EP (1) EP4240835A4 (https=)
JP (1) JP2023548560A (https=)
KR (1) KR20230104264A (https=)
WO (1) WO2022099069A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322674A (en) * 2023-02-09 2025-10-01 Funda??O D Anna De Sommer Champalimaud E Dr Carlos Montez Champalimaud Found Control of gene expression in cells expressing gamma and delta receptors
WO2024238691A2 (en) * 2023-05-15 2024-11-21 The Regents Of The University Of California Andp gene editing system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018008345A (es) * 2016-01-11 2018-12-06 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia.
IL260532B2 (en) * 2016-01-11 2023-12-01 Univ Leland Stanford Junior Chimeric proteins- containing systems and uses thereof in regulating gene expression
EP3784256A4 (en) * 2018-04-27 2022-06-29 Baylor College of Medicine Car t cells with one or more interleukins
CN110760480B (zh) * 2019-07-09 2021-07-02 杭州师范大学 一种抗肿瘤nk细胞及其制备方法

Similar Documents

Publication Publication Date Title
Liu et al. The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside
JP2023548560A5 (https=)
Kamata et al. Crosstalk: keratinocytes and immune cells in psoriasis
Donnelly et al. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes
Li et al. IL-17 receptor–based signaling and implications for disease
Kim et al. IFN-γ up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages
Vilček et al. Historical review: cytokines as therapeutics and targets of therapeutics
Donnelly et al. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes
Koj Initiation of acute phase response and synthesis of cytokines
JP2018514199A5 (https=)
Li et al. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy
Tanaka et al. Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system
Kolls et al. Interleukin-17: an emerging role in lung inflammation
CN103403166B (zh) 新的杂合启动子及包含其的重组载体
Nirula et al. Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
JP2018526450A5 (https=)
JP2020528758A5 (https=)
Rock et al. Tumor necrosis factor-α
Joshi et al. Mechanisms of mRNA translation of interferon stimulated genes
Yamagata et al. Targeting Th17 effector cytokines for the treatment of autoimmune diseases
JP2013516194A5 (https=)
Babadei et al. Transcriptional control of interferon-stimulated genes
Rani et al. Novel interferon-β-induced gene expression in peripheral blood cells
JP2023504282A5 (https=)
Xu et al. Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice